NCT07062055 2026-04-01
BITS-TO-HCC Study: HAIC+Iparomlimab/Tuvonralimab + Bevacizumab + SBRT for BCLC-C HCC With PVTT and/or Oligometastases
Shandong Cancer Hospital and Institute
Phase 2 Recruiting
Clinical Trials
10 trialsNCT06764095 2026-02-12
Enfortumab Vedotin and Pembrolizumab With Cystectomy and/or Ureterectomy for Locally Advanced or Metastatic Bladder and Upper Urothelial Tract Cancer, CAST-AI Trial
Mayo Clinic
Phase 4 Recruiting
NCT00929214 2025-12-17
Aggressive Local Therapy for Limited Bone-Only Metastasis to Improve Progression-Free Survival in Breast Cancer Patients
M.D. Anderson Cancer Center
Phase 2 Active not recruiting
NCT04681417 2025-11-28
RETINO 2018
Institut Curie
Phase 2/3 Recruiting
NCT02874040 2025-08-08
Endoresection of the Tumor Scar or Transpupillary Thermotherapy for the Treatment of Large Uveal Melanomas (Endoresection-Laser)
Institut Curie
Phase NA Completed
NCT06761937 2025-07-25
TANCA-I
Erasmus Medical Center
Phase 1 Recruiting
NCT05397262 2024-05-09
HyBla_RCT
University of Erlangen-Nürnberg Medical School
Phase NA Recruiting
NCT02898727 2022-11-22
Local HER-O
Trans Tasman Radiation Oncology Group
Phase NA Completed
NCT04803630 2022-05-12
Thermal Therapy for the Treatment of Depression in Cancer Survivors, the S-WARM Study
Roswell Park Cancer Institute
Phase EARLY_PHASE1 Withdrawn
NCT02452307 2017-08-17
Peptide-specific Vaccination in HLA-A*02 Positive Patients With Biochemical Recurrence After Radical Prostatectomy
University Hospital Tuebingen
Phase 1/2 Unknown